Axsome Therapeutics, Inc. AXSM
Super Investor & Insider
1
Fondi che lo detengono
#1456
Rank consenso
1.4%
% dei portafogli
$357,646
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| Polen Capital Management · Polen Capital Management | 0% | Buy | 2,116 | $357,646 |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Axsome Therapeutics is a commercial-stage biopharmaceutical company specializing in the development and commercialization of small-molecule medicines and novel therapies targeting central nervous system disorders. The company focuses on conditions with limited treatment options, including depression, Alzheimer's diseas…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees1,220
TickerAXSM
Statistics
Market Cap$12.92B
Revenue (TTM)$638.5M
Net Income-$183.2M
Net Margin-28.7%
EPS$-3.68
P/E-69.37
P/S18.44
P/B238.95
EV/EBITDA-75.29
ROE-349.4%
Dividend Yield—
Price$251.17
Data: Twelve Data · Revenue = mcap / P/S